ИСТИНА

Kubo M.

Соавторы: Philippe M., Бредер В.В., Fink R., Jeon S., Qin S., Zhu A., Bouattour M., Chen E., Danen A.L., Ducreux M., Fonn, Gally P., Garrido A. показать полностью..., Julie D., Kita K., Masafumi M., Minejima C., Mukai H., Mulak J., Mаксютов Ш.Ш., Ogasawara S., Perret E., Saira K., Siegel D., Thomas B., Tohjima Y., Ye, Ли Ю.Р., Чан С., Altmuller J., Alves M., Ang W.H., BAUER E., BUSH A., Bailey M.R., Barnes K.C., Baumhauer A., Beaty, Becker A., Beijing L.I., Beilby J., Bisgaard H., Bjornsdottir U.S., Bleeker A.J., Bonnelykke K., Boomsma D.I., Bossard M., Bouzigon E., Brightling C.E., Bronowicki J., Brui E.A., Bruno A.D., Brusselle G.G., CHEN H., Caruso G., Chan-Yeung M., Chen S., Cheng A., Cheng A., Cheng A., Cheng A., Cheng A., Chung K., Cookson W.O., Curtis J., Custovic A., Del-Rio-Navarro B.E., Demenais F., Donahue K.M., Duijts L., Ebinghaus M., Eriksson J.G., Farrell M., Feenstra B., Freidlin M.I., Gajdos Z., Gauderman J., Gehring U., Genuneit J., Gharib S.A., Gilliland F., Granato D., Granell R., Graves P.E., Gudbjartsson D.F., Guodong Z., György, Haahtela T., Heckbert S.R., Heederik D., Heinrich J., Heliovaara M., Henderson J., Himes B.E., Hirose Y., Hirschhorn J.N., Hofman A., Hottenga J., Huang Y., Hudson T.J., Humbert R., Imboden M., Jaddoe V.W., James A.S., Jansen C., Jarvis D., Jean-Christophe C., Jennifer L., Jiang H., Jones G.A., Jonsdottir I.S., Jousilahti P., Järvelin M., Kabesch M., Karonen M., Katsumata K., Kim T., Kim T., Koppelman G.H., Koyama Y., Kozyrskyj A.L., Kumar R.A., Kuokkanen M., König B., LATHROP M., LIANG X., LONDON S.J., Lahousse L., Laitinen T., Laprise C., Lau S.R., LeBerre M., Lee Y.М., Lehtimaki T., Letort S., Loehr L.R., Ma R., Manichaikul A., Margaritte-Jeannin P., Meng C.I., Narang J., Norquist J.M., Ollivier-Hourmand I., Reinhardt R., Reiser G., Rosmorduc O., Ross A.J., Ryoo B., Ryoo B., Song T., Tanimoto H., Toth D., Wang S., Wang Y., Xu D., Xu D., Yamagishi H., Yokosuka O., de Jongste J.C., Брюн С.П., Бурхард А.А., Ганьшин А.В., Жу, Иванов В.В., Кантор М.М., Карунас А.С., Касем Ф.М., Крейнес Е.М., Кумар A., Левин А.Ю., Мачида Т., Федорова Я.С., Хеллер Ф., Холст П., Хуснутдинова Э.К., ред ).

8 статей

Количество цитирований статей в журналах по данным Web of Science: 67, Scopus: 71

IstinaResearcherID (IRID): 16568159

Деятельность

• Статьи в журналах

  • • 2021 Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
    • Galle Peter R., Finn Richard S., Qin Shukui, Ikeda Masafumi, Zhu Andrew X., Kim Tae-You, Kudo Masatoshi, Breder Valeriy, Merle Philippe, Kaseb Ahmed, Li Daneng, Mulla Sohail, Verret Wendy, Xu Derek-Zhen, Hernandez Sairy, Ding Beiying, Liu Juan, Huang Chen, Lim Ho Yeong, Cheng Ann-Lii, Ducreux Michel
    • в журнале Lancet Oncology, издательство The Lancet Publishing Group (United Kingdom), том 22, № 7, с. 991-1001 DOI
  • • 2020 Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    • Finn Richard S., Qin Shukui, Ikeda Masafumi, Galle Peter R., Ducreux Michel, Kim Tae-You, Kudo Masatoshi, Breder Valeriy, Merle Philippe, Kaseb Ahmed O., Li Daneng, Verret Wendy, Xu Derek-Zhen, Hernandez Sairy, Liu Juan, Huang Chen, Mulla Sohail, Wang Yulei, Lim Ho Yeong, Zhu Andrew X., Cheng Ann-Lii
    • в журнале New England Journal of Medicine, издательство Massachusetts Medical Society (United States), том 382, № 20, с. 1894-1905 DOI
  • • 2020 Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240
    • Ryoo Baek-Yeol, Merle Philippe, Kulkarni Amit S., Cheng Ann-Lii, Bouattour Mohamed, Lim Ho Yeong, Breder Valeriy, Edeline Julien, Chao Yee, Ogasawara Sadahisa, Yau Thomas, Garrido Marcelo, Chan Stephen L., Daniele Bruno, Norquist Josephine M., Chen Erluo, Siegel Abby B., Zhu Andrew X., Finn Richard S., Kudo Masatoshi
    • в журнале Cancer, издательство John Wiley & Sons Inc. (United States), том 127, № 6, с. 865-874 DOI
  • • 2020 Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
    • Finn Richard S., Ryoo Baek-Yeol, Merle Philippe, Kudo Masatoshi, Bouattour Mohamed, Lim Ho Yeong, Breder Valeriy, Edeline Julien, Chao Yee, Ogasawara Sadahisa, Yau Thomas, Garrido Marcelo, Chan Stephen L., Knox Jennifer, Daniele Bruno, Ebbinghaus Scot W., Chen Erluo, Siegel Abby B., Zhu Andrew X., Cheng Ann-Lii
    • в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 38, № 3, с. 193-202 DOI
  • • 2018 Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks
    • Demenais F., Margaritte-Jeannin P., Barnes K.C., Cookson W.O.C, Altmuller J., Ang W., Barr R.G., Beaty T.H., Becker A.B., Beilby J., Bisgaard H., Bjornsdottir U.S., Bleecker E., Bonnelykke K., Boomsma D.I., Bouzigon E., Brightling C.E., Brossard M., Brusselle G.G., Burchard E., Burkart K.M., Bush A., Chan-Yeung M., Chung K.F., Alves A.C., Curtin J.A., Custovic A., Daley D., de Jongste J.C., Del-Rio-Navarro B.E., Donohue K.M., Duijts L., Eng C., Eriksson J.G., Farrall M., Fedorova Y., Feenstra B., Ferreira M.A., Freidin M.B., Gajdos Z., Gauderman J., Gehring U., Geller F., Genuneit J., Gharib S.A., Gilliland F., Granell R., Graves P.E., Gudbjartsson D.F., Haahtela T., Heckbert S.R., Heederik D., Heinrich J., Heliovaara M., Henderson J., Himes B.E., Hirose H., Hirschhorn J.N., Hofman A., Holt P., Hottenga J., Hudson T.J., Hui J., Imboden M., Ivanov V., Jaddoe V.W.V, James A., Janson C., Jarvelin M.R., Jarvis D., Jones G., Jonsdottir I., Jousilahti P., Kabesch M., Kahonen M., Kantor D.B., Karunas A.S., Khusnutdinova E., Koppelman G.H., Kozyrskyj A.L., Kreiner E., Kubo M., Kumar R., Kumar A., Kuokkanen M., Lahousse L., Laitinen T., Laprise C., Lathrop M., Lau S., Lee Y.A., Lehtimaki T., Letort S., Levin A.M., Li G, Liang L.M., Loehr L.R., London S.J., Loth D.W., Manichaikul A.
    • в журнале Nature Genetics, издательство Nature Publishing Group (United Kingdom), том 50, № 1, с. 42-+ DOI
  • • 2017 Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
    • Bruix Jordi, Qin Shukui, Merle Philippe, Granito Alessandro, Huang Yi-Hsiang, Bodoky György, Pracht Marc, Yokosuka Osamu, Rosmorduc Olivier, Breder Valeriy, Gerolami René, Masi Gianluca, Ross Paul J., Song Tianqiang, Bronowicki Jean-Pierre, Ollivier-Hourmand Isabelle, Kudo Masatoshi, Cheng Ann-Lii, Llovet Josep M., Finn Richard S., LeBerre Marie-Aude, Baumhauer Annette, Meinhardt Gerold, Han Guohong
    • в журнале The Lancet, издательство The Lancet Publishing Group (United Kingdom), том 389, № 10064, с. 56-66 DOI
  • 
    • 2014 Temporal changes in the emissions of CH4 and CO from China estimated from CH4/CO2 and CO/CO2 correlations observed at Hateruma Island
    • Tohjima Y., Kubo M., Minejima C., Mukai H., Tanimoto H., Ganshin A., Maksyutov S., Katsumata K., Machida T., Kita K.
    • в журнале Atmospheric Chemistry and Physics, издательство European Geophysical Society (Germany), том 14, № 3, с. 1663-1677 DOI
  • 
    • 2012 Analysis of Delta O-2/Delta CO2 ratios for the pollution events observed at Hateruma Island, Japan
    • Minejima C., Kubo M., Tohjima Y., Yamagishi H., Koyama Y., Maksyutov S., Kita K., Mukai H.
    • в журнале Atmospheric Chemistry and Physics, издательство European Geophysical Society (Germany), том 12, № 5, с. 2713-2723 DOI